Oncology Brothers: Discussions around the algorithm for DLBCL

Oncology Brothers shared on X:

“This is the algorithm we have used during our discussion on Diffuse large B cell lymphoma (DLBCL) with Carla Casulo.”

David Russler-Germain, Instructor for the Division of Oncology at the Washington University School of Medicine, replied:

“I will humbly argue that we should stick with RCHOP x4 or x3 plus RT for true limited stage disease.

These patients have 85-90% cure with 1L treatment, so even if swapping in Pola offered HR 0.8 improvement, NNT becomes 30-40.”

Source: Oncology Brothers/X and David Russler-Germain/X

Drs. Rohit Gosain and Rahul Gosain (aka Oncology Brothers), are medical oncologists/hematologists. Through their social media platforms like X/Twitter, they actively engage with their audience. With their own YouTube channel and podcast, they provide accessible resources for cancer patients and their families.

Additionally, their participation in live conferences ensures that cancer patients receive the best care closer to home, reflecting their commitment to advancing oncology and improving patient outcomes through education and outreach.